These findings are consistent with the finding that PPARA, PPARG, and PPARGC1A are located within clusters #1-2-3 and all of them are predicted to be progressively and simultaneously downregulated in IBD samples (Fig. 3e; based on the IBD map, Supplementary Fig. 1). Here, PPARA is linked to inflammatory bowel disease.